News

Apex Partners / News / SV Health Investors’ DDF to exit Caraway Therapeutics to Merck

SV Health Investors’ DDF to exit Caraway Therapeutics to Merck

November 21, 2023BharbourNews

Caraway Therapeutics is a biopharmaceutical company.

The post SV Health Investors’ DDF to exit Caraway Therapeutics to Merck appeared first on PE Hub.

Source: https://www.pehub.com/sv-health-investors-ddf-to-exit-caraway-therapeutics-to-merck/

Share this Story

Site Credit: Charlotte Web Design Agency Union

Securities offered through Burch & Company, Inc. member FINRA/SiPC 4151 N Mulberry Drive, Suite 435 Kansas City, MO 64116

Apex Partners and Burch & Company are not affiliated. Any advisory services discussed on this site that are required to be performed by a registered broker-dealer shall be performed by Burch & Company, Inc., through its registered agents, Barry Harbour or Jim McCoy. Apex Partners is not registered as a broker or dealer and therefore does not perform services that involve securities.

News

SV Health Investors’ DDF to exit Caraway Therapeutics to Merck

Share this Story

Recent Posts

Categories